Scotland’s cosmetic sector is set for sweeping regulatory changes in 2027, as clinics and practitioners prepare to comply with new licensing requirements for the first time. The overhaul stems from the Civic Government (Scotland) Act 1982 and the Non-surgical Procedures and Functions of Medical Reviewers (Scotland) Act 2026, which will bring treatments like Botox and dermal fillers under formal oversight after years of operating in an unregulated environment. The UK’s cosmetic surgery industry is estimated to be worth £3.6 billion, with non-surgical treatments such as Botox and dermal fillers accounting for 90 per cent of that figure.
The new framework introduces two levels of oversight. Lower-risk procedures, such as microneedling and non-ablative laser hair removal, will require licensing from local authorities. Higher-risk interventions, including injectables like dermal fillers and botulinum toxin, will face stricter controls. These must now be conducted exclusively in approved venues: registered clinics, hospitals, or medical, dental, or pharmacy facilities. Home-based and mobile services, previously widespread, will no longer qualify unless they meet the updated requirements.
Businesses across the industry must now conduct a full operational review. Practitioners will need to determine which treatments fall under the new classifications, verify whether their current premises comply, and confirm that staff possess the necessary qualifications and insurance coverage. Smaller operators, particularly those operating from home or through mobile setups, may face significant challenges in adapting to the changes. The financial burden of compliance, including licensing fees, staff training, and facility upgrades, could also lead to higher costs for consumers.
Read Also: Recycling firm loses bid to block SSPCA contract termination
Local councils will oversee enforcement, handling licence applications and compliance monitoring. With 32 separate authorities involved, maintaining consistency across Scotland will be essential for businesses operating in multiple regions. The reforms address long-standing regulatory gaps: as cosmetic procedures advanced and became more accessible, oversight failed to keep pace, creating opportunities for unqualified practitioners and unsafe conditions.
Scotland’s approach aligns with broader trends in the UK. England’s Health and Care Act 2022 includes provisions for a similar licensing scheme, though implementation details remain under discussion. The Scottish reforms establish a precedent, making it clear that unregulated cosmetic procedures will no longer be tolerated. For industry players, the September 2027 implementation deadline leaves less than two years to assess their position and prepare for compliance.